ORENCIA 750 mg QS 100 ml 0.9% NACL IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn...

FDA Drug Recall #D-1796-2019 — Class II — June 12, 2019

Recall Summary

Recall Number D-1796-2019
Classification Class II — Moderate risk
Date Initiated June 12, 2019
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Infusion Options, Inc.
Location Brooklyn, NY
Product Type Drugs
Quantity N/A

Product Description

ORENCIA 750 mg QS 100 ml 0.9% NACL IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233

Reason for Recall

Lack of Assurance of Sterility

Distribution Pattern

NY only

Lot / Code Information

All lots within expiry

Other Recalls from Infusion Options, Inc.

Recall # Classification Product Date
D-1786-2019 Class II INJECTAFER 720 MG in 100 ml NS IVPB; INJECTAFER... Jun 12, 2019
D-1746-2019 Class II Adcetris 96 MG/100 ML NS IVPB, Rx Only, Infusio... Jun 12, 2019
D-1768-2019 Class II DIPHENHYDRAMINE 25 MG/50 ML NS, Rx Only, Infusi... Jun 12, 2019
D-1769-2019 Class II DOCETAXEL 60 MG / 250 ml D5W IVPB; DOCETAXEL 71... Jun 12, 2019
D-1814-2019 Class II TOPOTECAN 1.24 MG / 100 ML NS IVPB, Rx Only, In... Jun 12, 2019

Frequently Asked Questions

Injectable drugs and eye drops must be completely free of microbial contamination because they bypass the body's natural defenses. A contaminated injectable can introduce bacteria or fungi directly into the bloodstream, potentially causing sepsis, meningitis, or localized infections — all of which can be life-threatening. Contamination of sterile products almost always results in a Class I recall. If you received an injectable drug from a recalled lot, contact your healthcare provider immediately, even if you feel well, as some infections can have delayed onset.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.